Literature DB >> 18669721

Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery.

Emma L Barber1, Guomao Zhao, Irina A Buhimschi, Jessica L Illuzzi.   

Abstract

OBJECTIVE: Intrapartum penicillin G prophylaxis aims to prevent early-onset group B streptococci (GBS) sepsis by interrupting vertical transmission. We examined the relationship between duration of prophylaxis and fetal serum penicillin G levels among fetuses exposed to fewer than 4 hours of prophylaxis compared with longer durations.
METHODS: In this prospective cohort study, 98 laboring GBS-positive women carrying singleton gestations at 37 weeks or greater were administered 5 million units of intravenous penicillin G followed by 2.5 million units every 4 hours until delivery. Umbilical cord blood samples were collected at delivery, and penicillin G levels were measured by high-performance liquid chromatography. Intraassay and interassay coefficients of variation were less than 3%.
RESULTS: Fetuses exposed to fewer than 4 hours of prophylaxis had higher penicillin G levels than those exposed to greater than 4 hours (P=.003). In multivariable linear regression analysis, fetal penicillin G levels were determined by duration of exposure, time since last dose, dosage, and number of doses, but not maternal body mass index. Penicillin G levels increased linearly until 1 hour (R(2)=.40) and then decreased rapidly according to a power-decay model (R(2)=.67). All subgroups analyzed were above the minimal inhibitory concentration (MIC) for GBS (0.1 micrograms/mL)(P<.002). Individual samples were 10-179-fold above the MIC. In patients receiving maintenance dosing, penicillin G did not accumulate in the cord blood and returned to baseline after each 4-hour interval.
CONCLUSION: Short durations of prophylaxis achieved levels significantly above the MIC, suggesting a benefit even in precipitous labors. The designation of infants exposed to fewer than 4 hours of prophylaxis as particularly at risk for GBS sepsis may be pharmacokinetically inaccurate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669721      PMCID: PMC3144749          DOI: 10.1097/AOG.0b013e31817d0246

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

1.  Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn.

Authors:  Mary C Ottolini; Kathleen Lundgren; Laura J Mirkinson; Sheila Cason; Martin G Ottolini
Journal:  Pediatr Infect Dis J       Date:  2003-05       Impact factor: 2.129

2.  Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus.

Authors:  J R Johnson; D F Colombo; D Gardner; E Cho; P Fan-Havard; C S Shellhaas
Journal:  Am J Obstet Gynecol       Date:  2001-10       Impact factor: 8.661

3.  Pharmacokinetics of penicillin g in very-low-birth-weight neonates.

Authors:  Tuuli Metsvaht; Kersti Oselin; Mari-Liis Ilmoja; Kaili Anier; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  Maternal and transplacental pharmacokinetics of cefazolin.

Authors:  T Fiore Mitchell; M D Pearlman; R L Chapman; V Bhatt-Mehta; R G Faix
Journal:  Obstet Gynecol       Date:  2001-12       Impact factor: 7.661

5.  Evidence for a slow elimination phase for penicillin G.

Authors:  S C Ebert; J Leggett; B Vogelman; W A Craig
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

6.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale.

Authors:  K M Boyer; C A Gadzala; L I Burd; D E Fisher; J B Paton; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

7.  Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization.

Authors:  R L Davis; M B Hasselquist; V Cardenas; D M Zerr; J Kramer; A Zavitkovsky; A Schuchat
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

8.  Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.

Authors:  K M Boyer; S P Gotoff
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

9.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Authors:  Stephanie Schrag; Rachel Gorwitz; Kristi Fultz-Butts; Anne Schuchat
Journal:  MMWR Recomm Rep       Date:  2002-08-16

10.  Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns.

Authors:  M Pylipow; M Gaddis; J S Kinney
Journal:  Pediatrics       Date:  1994-04       Impact factor: 7.124

View more
  6 in total

1.  Interpretation of 2002 Centers for Disease Control guidelines for group B streptococcus and evolving provider practice patterns.

Authors:  Emma L Barber; Edmund F Funai; Michael B Bracken; Jessica L Illuzzi
Journal:  Am J Perinatol       Date:  2010-07-16       Impact factor: 1.862

Review 2.  Drugs for the Prevention and Treatment of Sepsis in the Newborn.

Authors:  Sagori Mukhopadhyay; Kelly C Wade; Karen M Puopolo
Journal:  Clin Perinatol       Date:  2019-03-30       Impact factor: 3.430

3.  Maternal infection in pregnancy and risk of asthma in offspring.

Authors:  Charlene H Collier; Kari Risnes; Errol R Norwitz; Michael B Bracken; Jessica L Illuzzi
Journal:  Matern Child Health J       Date:  2013-12

4.  Intrapartum group B Streptococcal prophylaxis and childhood weight gain.

Authors:  Sagori Mukhopadhyay; Karen Marie Puopolo; Matthew Bryan; Miren B Dhudasia; William Quarshie; Jeffrey S Gerber; Robert W Grundmeier; Corinna Koebnick; Margo A Sidell; Darios Getahun; Andrea J Sharma; Michael W Spiller; Stephanie J Schrag
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2021-05-06       Impact factor: 5.747

Review 5.  Challenges in reducing group B Streptococcus disease in African settings.

Authors:  Yo Nishihara; Ziyaad Dangor; Neil French; Shabir Madhi; Robert Heyderman
Journal:  Arch Dis Child       Date:  2016-10-18       Impact factor: 3.791

6.  Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis.

Authors:  Mark A Turrentine; Anthony J Greisinger; Kimberly S Brown; Oscar A Wehmanen; Melanie E Mouzoon
Journal:  Infect Dis Obstet Gynecol       Date:  2013-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.